Hypoxia and Hemodilution Testing in Healthy Adult Volunteers
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-35
SponsorNihon Kohden
About this trial
This study will collect physiological measurements in healthy adult volunteers under controlled hypoxia and hemodilution conditions.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
In good general health with no evidence of significant medical problems.
Fluent in both written and spoken English.
Disqualifiers
BMI above 30.
History of heart, lung, kidney, or liver disease.
Diagnosis of asthma, sleep apnea, or use of CPAP.
Diabetes mellitus.
Trial population
Healthy adult volunteers. At least 7 subjects will be enrolled. Subjects will be selected with reference to ISO and FDA requirements to ensure appropriate representation across skin tone categories (Monk Skin Tone scale) and sex.
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Noninvasive Physiological Monitoring Device
DeviceOctopal R Noninvasive Pulse Wave Measuring Device DMO-8000X with TL 811S Finger Probe
Treatment groups
7 Participants
are divided into 1 treatment groupGroup A: Adult healthy subjects1 intervention
Trial outcomes
Primary outcomes
1
Collection of Hemoglobin and Oxygen Saturation Measurements
Collect device readings of oxygen saturation and hemoglobin concentration and reference values obtained from arterial blood samples analyzed using a multi-wavelength laboratory oximeter.
Time frame
From enrollment to the end of treatment up to 8 hoursSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: